NCT01436734View on ClinicalTrials.gov

Role of Aprotinin in Glucagon Degradation, Measurement by Radioimmunoactive Method (RIA) I125

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

May 31, 2013

Conditions
Hyperglucagonemia
Interventions
OTHER

Fasting glycemia

no intervention

OTHER

Hypoglycemia

Insulin induced hypoglycemia

Trial Locations (1)

2900

Gentofte Hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT01436734 - Role of Aprotinin in Glucagon Degradation, Measurement by Radioimmunoactive Method (RIA) I125 | Biotech Hunter | Biotech Hunter